Research on gastric cancer cells has shown that CD44 increases the production of IL‐8 by CAFs, and in GCTB cancer cells, the SRGN/CD44/FAK system induces osteoclast differentiation from monocytes, supporting tumor progression [16, 20]. This evidence concerns the gene CD44 and gastric cancer.